CONCI, NICOLE
 Distribuzione geografica
Continente #
NA - Nord America 216
EU - Europa 178
AS - Asia 110
AF - Africa 24
OC - Oceania 3
Totale 531
Nazione #
US - Stati Uniti d'America 216
IT - Italia 76
VN - Vietnam 31
SG - Singapore 27
CN - Cina 26
DE - Germania 26
SE - Svezia 26
IN - India 17
GB - Regno Unito 13
IE - Irlanda 13
TG - Togo 10
CI - Costa d'Avorio 8
NG - Nigeria 6
BG - Bulgaria 5
JO - Giordania 5
CH - Svizzera 4
ES - Italia 4
FI - Finlandia 4
AU - Australia 3
ID - Indonesia 2
JP - Giappone 2
RU - Federazione Russa 2
BE - Belgio 1
FR - Francia 1
NL - Olanda 1
PT - Portogallo 1
UA - Ucraina 1
Totale 531
Città #
Dong Ket 30
Chandler 27
Singapore 21
Ashburn 20
Seattle 20
Fairfield 17
Woodbridge 14
Dublin 13
Bologna 12
Southend 11
Houston 10
Lomé 10
Wilmington 9
Abidjan 8
Cambridge 8
Princeton 8
Santa Clara 8
Moncalieri 7
Rome 7
Abeokuta 6
Amman 5
Hyderabad 5
Sofia 5
Beijing 4
Berlin 4
Bern 4
Helsinki 4
New York 4
Seville 4
Bremen 3
Jinan 3
Redmond 3
San Diego 3
Borgomanero 2
Brescia 2
Des Moines 2
Ferrara 2
Jakarta 2
Manchester 2
Melbourne 2
Palermo 2
Pune 2
Saitama 2
Shanghai 2
Amsterdam 1
Ann Arbor 1
Boydton 1
Brussels 1
Bühl 1
Canberra 1
Chicago 1
Chions 1
Falkenstein 1
Genova 1
Hamburg 1
Hangzhou 1
Hanoi 1
Jinhua 1
Montepulciano 1
Munich 1
Mülheim 1
Nanjing 1
Ningbo 1
Olalla 1
Redwood City 1
Reggio Nell'emilia 1
San Francisco 1
Secaucus 1
Taizhou 1
Trieste 1
Turin 1
Udine 1
Westminster 1
Yueqing 1
Totale 369
Nome #
Comparison of Sequential Testing and Next Generation Sequencing in advanced Lung Adenocarcinoma patients – A single centre experience 190
The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter 109
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non–small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors 69
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. 55
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 46
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis 40
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 22
How Do Molecular Classifications Affect the Neoadjuvant Treatment of Muscle-Invasive Urothelial Carcinoma? 14
First-Generation Epidermal Growth Factor Receptor Inhibitors Plus Antiangiogenic Drugs Versus Third-Generation Epidermal Growth Factor Receptor Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis 5
Ad(aura): a fresh breeze for patients with resected EGFR-mutant non-small cell lung cancer 4
Totale 554
Categoria #
all - tutte 2.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 1 10 5 7 1 2
2020/2021109 4 2 1 1 34 23 1 1 3 2 1 36
2021/2022102 3 0 2 3 5 3 0 22 9 8 30 17
2022/2023156 13 29 7 16 15 9 4 11 30 2 9 11
2023/202480 7 10 3 5 7 24 4 4 5 4 5 2
2024/202581 21 29 19 12 0 0 0 0 0 0 0 0
Totale 554